Click on a field for details on how to access that data via Web API, Excel, or CSV File Download.
| Open Price | |
| High Price | |
| Low Price | |
| Close Price | |
| Change | |
| Percent Change | |
| Volume |
| Avg Daily Volume | 108,236 |
| 52 Week High | $5.76 |
| 52 Week Low | $3.03 |
| Target Price | N/A |
| Ticker | TTNP:UW |
| Composite Ticker | TTNP:US |
| Security Name | Titan Pharmaceuticals, Inc. (de) |
| Type | Ordinary Shares |
| Class | TTNP |
| Currency | USD |
| Round Lot Size | 100 |
| Primary | Yes |
| Delisted | No |
| ETF | No |
| Market Category | Common Stock |
| Market Sector | Equity |
| Exchange Symbol | ^USCOMP |
| Exchange Name | US COMPOSITE |
| Exchange City | N/A |
| Exchange Country | UNITED STATES OF AMERICA |
| Exchange Website | N/A |
| FIGI | BBG000BTGY29 |
| Composite FIGI | BBG000BTGSY7 |
| Share Class FIGI | BBG001S72H65 |
| FIGI Unique ID | N/A |
| Dividend | $1,462.50 |
| Dividend Rate | $1,462.50 |
| Trailing Dividend Yield | 0.00% |
| 5-year Average Dividend Yield | 0.00% |
| Dividend Ex Date | 2024-01-09 |
| Beta | 0.2236 |
| 1-year beta | 0.6461 |
| 3-year beta | 0.2236 |
| 5-year beta | 0.4411 |
| 7-year beta | 0.6369 |
| 10-year beta | 0.7524 |
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.
